COLCRYS(R) (Colchicine, USP) Shows Superior Safety With Comparable …

Low-dosing of Oral Colchicine for Early Acute Gout Flare: Twenty-Four Hour Outcome Results of the First Randomized , Placebo- Controlled , Dose Comparison Colchicine Trial ,” details the AGREE (Acute Gout Flare Receiving Colchicine … The study was published in the April issue of Arthritis & Rheumatism, the official journal of the American College of Rheumatology. AGREE formed the basis for URL Pharma’s New Drug Application (NDA) submission for Colcrys to the U.S.

More:
COLCRYS(R) (Colchicine, USP) Shows Superior Safety With Comparable …

No comments yet.

TOP